Sucralfate
NDC 62135-106, Sucralfate, suspension, from Chartwell RX, LLC.
- Product NDC
- 62135-106
- Status
- Listed
- Labeler
- Chartwell RX, LLC
- Dosage form
- SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA211780
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/62135-106 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- SUCRALFATE1 g/10mL
Pharmacologic classes
Aluminum Complex [EPC]; Organometallic Compounds [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 62135-106-44 | 62135010644 | 420 mL in 1 BOTTLE (62135-106-44) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/37aee721-b9c7-4e6b-a1a1-e826d8541d6b
Use it
Look up 62135-106 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/62135-106 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 62135-106. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.